{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:33:44Z","timestamp":1770435224767,"version":"3.49.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2002,2,26]]},"DOI":"10.1212\/wnl.58.4.662","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:59:37Z","timestamp":1336917577000},"page":"662-663","source":"Crossref","is-referenced-by-count":41,"title":["Zolpidem improves dystonia in \u201cLubag\u201d or X-linked dystonia-parkinsonism syndrome"],"prefix":"10.1212","volume":"58","author":[{"given":"Virgilio Gerald H.","family":"Evidente","sequence":"first","affiliation":[{"name":"From the Department of Neurology, Mayo Clinic, Scottsdale, AZ."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","unstructured":"Evidente VGH Singleton A Gwinn-Hardy K Hardy J. X-linked dystonia (\u201cLubag\u201d) presenting as pure parkinsonism: a more benign phenotype? Mov Disord 2001 (in press).","DOI":"10.1002\/mds.1263"},{"key":"e_1_3_1_3_2","first-page":"865","volume":"59","year":"2000","unstructured":"Holm KJ, Goa KL. Zolpidem. An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs . 2000; 59: 865\u2013889.","journal-title":"An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs"},{"key":"e_1_3_1_4_2","first-page":"1222","volume":"349","year":"1997","unstructured":"Daniele A, Albanese A, Gainotti G, Gregori B, Bartolomeo P. Zolpidem in Parkinson\u2019s disease. Lancet . 1997; 349: 1222\u20131223. Letter.","journal-title":"Lancet"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908123410721"},{"key":"e_1_3_1_6_2","unstructured":"Tarsy   D.   Dystonia. In:  Ahlskog  JE Adler  CH eds.  Parkinson\u2019s disease and movement disorders: diagnosis and treatment guidelines for the practicing physician.   Totowa NJ:   Humana Press 2000;  297\u2013311."},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00334-2"},{"key":"e_1_3_1_8_2","unstructured":"Langer   SZ Arbilla   S Scatton   BV Niddam   R Dubois   A.   Receptors involved in the mechanism of action of zolpidem. In:  Sauvanet  JP Langer  SZ Morselli  PL eds.  Imidazopyridines in sleep disorders: a novel experimental and therapeutic approach.   New York:   Raven Press 1988;  55\u201370."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.58.4.662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T17:50:35Z","timestamp":1711648235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.58.4.662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,26]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,2,26]]}},"alternative-id":["10.1212\/WNL.58.4.662"],"URL":"https:\/\/doi.org\/10.1212\/wnl.58.4.662","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2,26]]}}}